\
&
Contact us
\
&
Contact us
This was 1 year ago
Locationonline
Programmes
On 11 June 2024, the European Innovation Council and SMEs Executive Agency (EISMEA) is organising an informative webinar to learn more about the following calls:
- HORIZON-EIE-2024-CONNECT-02-01: Expanding Academia-Enterprise Collaborations
- HORIZON-EIE-2024-CONNECT-02-02: Mutual learning and support scheme for national and regional innovation programmes
Registration will end on Sunday 9 June 2024, 12:00 (CEST)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
